Literature DB >> 10606976

Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

T Wada1, K Takei, M Kudo, S Shimura, Y Kasahara, S Koizumi, K Kawa-Ha, Y Ishida, S Imashuku, H Seki, A Yachie.   

Abstract

Omenn syndrome was recently found to be caused by missense mutations in RAG1 or RAG2 gene that result in partial V(D)J recombination activity. Although the clinical hallmarks of the disease are well defined, there have been several cases with clinical findings similar to, but distinct from Omenn syndrome. The data on immune functions and RAG gene mutations of such cases are limited. We described five Japanese infants from four unrelated families, including two cases of Omenn syndrome and three cases of related disorders. Sibling cases with typical Omenn phenotype were found to be compound heterozygotes of R396C and L885R mutations in RAG1. The former has been reported in European cases and may constitute a hot spot. The latter is a novel missense mutation. Infants with related disorders exhibited erythroderma, eosinophilia, hypogammaglobulinaemia, decreased number of B cells and skewing to Th2, and their lymph node specimens showed architectural effacement, lymphocyte depletion and histiocytic hyperplasia, each of which is seen characteristically in Omenn syndrome. However, in these cases serum IgE levels were low or undetectable. We found no mutation in RAG genes except for a K820R substitution in RAG1, which was regarded to be a functional polymorphism, in two of these cases. Our study suggests that RAG missense mutation may be a genetic abnormality unique to Omenn syndrome with characteristic clinical and laboratory findings. Variations of Omenn syndrome, or related disorders, may represent a different type of immunodeficiency, distinct from abnormalities in lymphoid-specific recombinase activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606976      PMCID: PMC1905546          DOI: 10.1046/j.1365-2249.2000.01101.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  FAMILIAL RETICULOENDOTHELIOSIS WITH EOSINOPHILIA.

Authors:  G S OMENN
Journal:  N Engl J Med       Date:  1965-08-19       Impact factor: 91.245

2.  Immune status in two brothers with Omenn's syndrome: no discernible chimerism on FACS analysis using a monoclonal antibody specific for a maternally restricted HLA antigen.

Authors:  T Tachinami; S Koizumi; A Yachie; M Yamagami; T Yokoi; I Ohno; N Taniguchi; I Takada; A Kawashima; Y Okada
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

3.  Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

Authors:  G de Saint-Basile; F Le Deist; J P de Villartay; N Cerf-Bensussan; O Journet; N Brousse; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Clinical and immunological findings in four infants with Omenn's syndrome: a form of severe combined immunodeficiency with phenotypically normal T cells, elevated IgE, and eosinophilia.

Authors:  L Businco; A Di Fazio; M G Ziruolo; A L Boner; E A Valletta; L P Ruco; D Vitolo; B Ensoli; R Paganelli
Journal:  Clin Immunol Immunopathol       Date:  1987-08

5.  Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease.

Authors:  D P Wirt; E G Brooks; S Vaidya; G R Klimpel; T A Waldmann; R M Goldblum
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

6.  Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency.

Authors:  M T Glover; D J Atherton; R J Levinsky
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

7.  Omenn's syndrome--pathologic arguments in favor of a graft versus host pathogenesis: a report of nine cases.

Authors:  H Jouan; F Le Deist; C Nezelof
Journal:  Hum Pathol       Date:  1987-11       Impact factor: 3.466

8.  Combined immunodeficiency and reticuloendotheliosis with eosinophilia.

Authors:  H D Ochs; S D Davis; E Mickelson; K G Lerner; R J Wedgwood
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

9.  Omenn's syndrome and related combined immunodeficiency syndromes: diagnostic considerations in infants with persistent erythroderma and failure to thrive.

Authors:  R A Pupo; S K Tyring; S S Raimer; D P Wirt; E G Brooks; R M Goldblum
Journal:  J Am Acad Dermatol       Date:  1991-08       Impact factor: 11.527

10.  Omenn's disease.

Authors:  M P Dyke; N Marlow; P J Berry
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

View more
  7 in total

1.  High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

Authors:  Sabrina Battista; Monica Fedele; Josefina Martinez Hoyos; Francesca Pentimalli; Giovanna Maria Pierantoni; Rosa Visone; Ivana De Martino; Carlo Maria Croce; Alfredo Fusco
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

2.  Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.

Authors:  Xiaomin Yu; Jorge R Almeida; Sam Darko; Mirjam van der Burg; Suk See DeRavin; Harry Malech; Andrew Gennery; Ivan Chinn; Mary Louise Markert; Daniel C Douek; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2014-01-07       Impact factor: 10.793

3.  Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.

Authors:  Ponpan Matangkasombut; Muriel Pichavant; Doris E Saez; Silvia Giliani; Evelina Mazzolari; Andrea Finocchi; Anna Villa; Cristina Sobacchi; Patricia Cortes; Dale T Umetsu; Luigi D Notarangelo
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

Review 4.  Diagnostic role of tests for T cell receptor (TCR) genes.

Authors:  E Hodges; M T Krishna; C Pickard; J L Smith
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

Review 5.  RAG Deficiency: Two Genes, Many Diseases.

Authors:  Ottavia M Delmonte; Catharina Schuetz; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2018-07-25       Impact factor: 8.317

Review 6.  Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.

Authors:  Blaine Crowley; Melanie Ruffner; Donna M McDonald McGinn; Kathleen E Sullivan
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

7.  Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System.

Authors:  Cameron L Gardner; Mara Pavel-Dinu; Kerry Dobbs; Marita Bosticardo; Paul K Reardon; Justin Lack; Suk See DeRavin; Kent Le; Ezekiel Bello; Francesca Pala; Ottavia M Delmonte; Harry Malech; Amelie Montel-Hagan; Gay Crooks; Oreste Acuto; Matthew H Porteus; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2021-03-01       Impact factor: 8.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.